S
Sangyong Lim
Researcher at Korea University of Science and Technology
Publications - 112
Citations - 1762
Sangyong Lim is an academic researcher from Korea University of Science and Technology. The author has contributed to research in topics: Deinococcus radiodurans & Deinococcus. The author has an hindex of 21, co-authored 105 publications receiving 1353 citations.
Papers
More filters
Journal ArticleDOI
Conservation and diversity of radiation and oxidative stress resistance mechanisms in Deinococcus species
TL;DR: Comparisons improved the characterisation of several proteins regarding important conserved residues, cellular location and possible protein–protein interactions and indicates not only conservation but also large diversity in the molecular mechanisms involved in radiation resistance even within the Deinococcus genus.
Journal ArticleDOI
Melittin, a honeybee venom‑derived antimicrobial peptide, may target methicillin‑resistant Staphylococcus aureus.
Ji Hae Choi,A Yeung Jang,Shunmei Lin,Sangyong Lim,Dongho Kim,Kyungho Park,Sang Mi Han,Joo Hong Yeo,Ho Seong Seo +8 more
TL;DR: It is demonstrated for the first time, to the best of the knowledge, that melittin may be used as a promising antimicrobial agent to enhance the healing of MRSA-induced wounds.
Journal ArticleDOI
LsrR-mediated quorum sensing controls invasiveness of Salmonella typhimurium by regulating SPI-1 and flagella genes.
TL;DR: It is reported that the LsrR protein, a transcriptional regulator known to be involved in LuxS/AI-2-mediated QS, is also associated with the regulation of SPI-1-mediated Salmonella virulence, and results imply that LSRR plays an important role in selecting infectious niche ofSalmonella in QS dependent mode.
Journal ArticleDOI
Pigment-based whole-cell biosensor system for cadmium detection using genetically engineered Deinococcus radiodurans
TL;DR: Results indicate that genetically engineered D. radiodurans (KDH081) can be used to monitor the presence of Cd macroscopically and shows the highest specificity, sensitivity, and activity in response to Cd.
Journal ArticleDOI
Status of group B streptococcal vaccine development
TL;DR: The history of GBS infections, the current vaccine candidates, and the current status of immunogenicity assays used to evaluate the clinical efficacy of GB streptococcus vaccines are reviewed.